Placental Productions and Expressions of Soluble Endoglin, Soluble Fms-like Tyrosine Kinase Receptor-1, and Placental Growth Factor in Normal and Preeclamptic Pregnancies

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2007 Oct 25

PMID 17956952

Citations 55

Authors

Yang Gu

David F Lewis

Yuping Wang

Affiliations

Soon will be listed here.

Abstract

Context: Increased production of antiangiogenic factors soluble endoglin (sEng) and soluble fms-like tyrosine kinase receptor-1 (sFlt-1) by the placenta contributes to the pathophysiology in preeclampsia (PE).

Objective: Our objective was to determine the differences in endoglin (Eng), fms-like tyrosine kinase receptor-1 (Flt-1), and placental growth factor (PlGF) expressions between normal and PE placentas and sEng, sFlt-1, and PlGF production by trophoblast cells (TC) cultured under lowered oxygen conditions.

Methods: TCs isolated from normal and PE placentas were cultured under regular (5% CO2/air) and lowered (2% O2/5% CO2/93% N2) oxygen conditions. sEng, sFlt-1, and PlGF productions were determined by ELISA. Protein expressions for Eng, Flt-1, and PlGF in the placental tissues were accessed by immunohistochemical staining and Western blot analysis. Deglycosylated Eng, Flt-1, and PlGF protein expressions in placental tissues were also examined.

Results: PE TCs produced significantly more sEng, sFlt-1, and PlGF compared with those from normal TCs (P < 0.05). Under lowered oxygen conditions, PE TCs, but not normal TCs, released more sEng and sFlt-1. In contrast, both normal and PE TCs released less PlGF (P < 0.05). Enhanced expressions of Eng and Flt-1, as well as glycosylated Eng and Flt-1, were observed in PE placentas. Immunoblot also revealed that TCs released glycosylated sFlt-1, but not sEng, in culture.

Conclusions: PE TCs produce more sEng, sFlt-1, and PlGF than normal TCs. Lowered oxygen conditions promote sEng and sFlt-1, but reduce PlGF, productions by PE TCs. More glycosylated sEng and sFlt-1 are present in PE placentas. Trophoblasts release glycosylated sFlt-1, but unglycosylated sEng, in culture.

Citing Articles

Placental expression and methylation of angiogenic factors in assisted reproductive technology pregnancies from India.

Sundrani D, Kapare A, Yadav H, Randhir K, Gupte S, Joshi S Epigenomics. 2024; 17(1):21-31.

PMID: 39655657 PMC: 11703132. DOI: 10.1080/17501911.2024.2438593.

High-fat, high-carbohydrate diet-induced prediabetes preconception in Sprague-Dawley rats as a risk factor for the development of preeclampsia: assessing changes in placental metabolic insults.

Ludidi A, Siboto A, Nkosi A, Xulu N, Khathi A, Sibiya N Front Nutr. 2023; 10:1241785.

PMID: 37937252 PMC: 10626547. DOI: 10.3389/fnut.2023.1241785.

Pathophysiology of Preeclampsia and L-Arginine/L-Citrulline Supplementation as a Potential Strategy to Improve Birth Outcomes.

Ortiz-Cerda T, Mosso C, Alcudia A, Vazquez-Roman V, Gonzalez-Ortiz M Adv Exp Med Biol. 2023; 1428:127-148.

PMID: 37466772 DOI: 10.1007/978-3-031-32554-0_6.

Comparing the results from a Swedish pregnancy cohort using data from three automated placental growth factor immunoassay platforms intended for first-trimester preeclampsia prediction.

Carlsson Y, Sandstrom A, Bergman L, Conner P, Hansson S, Kublickas M Acta Obstet Gynecol Scand. 2023; 102(8):1084-1091.

PMID: 37358242 PMC: 10378007. DOI: 10.1111/aogs.14615.

Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis?.

Martin-Estal I, Castorena-Torres F Front Endocrinol (Lausanne). 2022; 13:916042.

PMID: 35813659 PMC: 9259869. DOI: 10.3389/fendo.2022.916042.

References

Walsh S, Wang Y . Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab. 1995; 80(6):1888-93. DOI: 10.1210/jcem.80.6.7775637. View

Bowen R, Zhang Y, Gu Y, Lewis D, Wang Y . Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclamptic pregnancies cultured under hypoxia condition. Placenta. 2005; 26(5):402-9. DOI: 10.1016/j.placenta.2004.07.007. View

Levine R, Maynard S, Qian C, Lim K, England L, Yu K . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350(7):672-83. DOI: 10.1056/NEJMoa031884. View

Raab U, Velasco B, Lastres P, Letamendia A, Cales C, Langa C . Expression of normal and truncated forms of human endoglin. Biochem J. 1999; 339 ( Pt 3):579-88. PMC: 1220193. View

Park J, Chen H, Winer J, Houck K, Ferrara N . Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem. 1994; 269(41):25646-54. View

Toporsian M, Gros R, Kabir M, Vera S, Govindaraju K, Eidelman D . A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res. 2005; 96(6):684-92. DOI: 10.1161/01.RES.0000159936.38601.22. View

Gougos A, Letarte M . Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem. 1990; 265(15):8361-4. View

Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D . Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003; 9(7):936-43. DOI: 10.1038/nm884. View

Wang Y, Walsh S . Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig. 1996; 3(4):179-84. View

10.

Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G . Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem. 1997; 272(16):10382-8. DOI: 10.1074/jbc.272.16.10382. View

11.

Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K . Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007; 115(13):1789-97. DOI: 10.1161/CIRCULATIONAHA.106.660134. View

12.

Li H, Gu B, Zhang Y, Lewis D, Wang Y . Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta. 2005; 26(2-3):210-7. DOI: 10.1016/j.placenta.2004.05.004. View

13.

Wang Y, Walsh S . Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta. 2001; 22(2-3):206-12. DOI: 10.1053/plac.2000.0608. View

14.

Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim Y . Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006; 12(6):642-9. DOI: 10.1038/nm1429. View

15.

Kendall R, Thomas K . Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993; 90(22):10705-9. PMC: 47846. DOI: 10.1073/pnas.90.22.10705. View

16.

Walsh S, Behr M, Allen N . Placental prostacyclin production in normal and toxemic pregnancies. Am J Obstet Gynecol. 1985; 151(1):110-5. DOI: 10.1016/0002-9378(85)90435-1. View

17.

Nagy J, Dvorak A, Dvorak H . VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med. 2003; 13(5):169-75. DOI: 10.1016/s1050-1738(03)00056-2. View

18.

Rajakumar A, Doty K, Daftary A, Harger G, Conrad K . Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta. 2003; 24(2-3):199-208. DOI: 10.1053/plac.2002.0893. View

19.

Lis H, Sharon N . Protein glycosylation. Structural and functional aspects. Eur J Biochem. 1993; 218(1):1-27. DOI: 10.1111/j.1432-1033.1993.tb18347.x. View

20.

Levine R, Lam C, Qian C, Yu K, Maynard S, Sachs B . Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355(10):992-1005. DOI: 10.1056/NEJMoa055352. View